Paradigm Biopharmaceuticals | PAR - Interest Expense On Debt

Stock Price
0.25
Daily Change
-0.01 -3.85%
Monthly
-13.79%
Yearly
-40.48%
Q1 Forecast
0.25

Paradigm Biopharmaceuticals reported AUD1000 in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Avita Medical AUD 1.25M 100K Jun/2025
Medical Developments International AUD 18K 3K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
PYC Therapeutics AUD 17K 11K Jun/2025
Telix Pharmaceuticals AUD 7.62M 11.22M Dec/2025